The Baltimore Ravens’ pursuit of Las Vegas Raiders edge rusher Maxx Crosby captivated the NFL world for a brief, intense period this week. A deal reportedly involving two first-round draft picks was agreed to, then abruptly canceled, leaving fans and analysts scrambling for answers. The core issue, it turns out, wasn’t a last-minute change of heart, but a concerning discovery during Crosby’s medical evaluation: a degenerative knee issue that raised long-term durability questions for the Ravens.
The revelation, first reported by ESPN, casts a new light on Baltimore’s decision. While Crosby has proven himself a relentless force on the field – a five-time Pro Bowler known for his tenacity – the Ravens’ medical team apparently identified a condition that could significantly impact his ability to maintain that level of play beyond the 2026 season. This isn’t simply about the knee surgery Crosby underwent in January to address a meniscus tear; it’s a deeper, more fundamental concern about the long-term health of the joint.
A Degenerative Condition Raises Concerns
The specifics of the “degenerative knee issue” remain closely guarded, but the term itself suggests a progressive condition, likely involving cartilage breakdown or osteoarthritis. While Crosby played through the meniscus tear in the latter half of the 2025 season, the underlying issue was apparently flagged during the Ravens’ thorough medical examination. This isn’t to say Crosby is incapable of playing at a high level now, but rather that Baltimore’s assessment indicated a heightened risk of future complications and a potential decline in performance.
Ravens General Manager Eric DeCosta acknowledged the team’s disappointment in having to pull out of the trade, stating he was “gutted” by the outcome. However, he also emphasized the importance of due diligence in evaluating a player’s health. “We’ve done a lot of different trades,” DeCosta told reporters. “One of the key things is you bring the player in and try to get as much information as you can. We did that, and we were not able to complete the process of acquiring the player based on our assessment of the situation.”
The Raiders’ Perspective and Crosby’s Response
The failed trade leaves the Raiders with Crosby, a cornerstone of their defense and a fan favorite. The team reportedly wasn’t thrilled with how the situation unfolded, with some league executives, as reported by Fox Sports, expressing frustration with the Ravens’ handling of the deal. One executive was quoted as saying, “Whatever they saw [in their medical exam] better be career-threatening, otherwise you don’t do this.”
Those close to Crosby quickly defended his health and readiness to play. Crosby’s agent, CJ Labot, took to X (formerly Twitter) to state that Crosby “continues to be on track in his recovery and if anything is ahead of schedule according to his surgeon Dr. Neal ElAttrache.”
Maxx continues to be on track in his recovery and if anything is ahead of schedule according to his surgeon Dr Neal El Attrache. Maxx remains on track to return during the offseason program & will undoubtedly return as the dominant game wrecker he has been these past 7 seasons. https://t.co/wJq9q9q999
— CJ LaBoy (@CJLaBoy) March 12, 2024
Dr. ElAttrache himself subsequently released a statement to ESPN confirming Crosby’s positive progress in rehabilitation from his meniscus tear and related stress injury.
Ravens Pivot to Hendrickson
Despite the setback in acquiring Crosby, the Ravens moved swiftly to address their require for an edge rusher. Within a day of pulling out of the Crosby trade, they agreed to a four-year deal with Trey Hendrickson, a proven pass rusher who spent the last three seasons with the Cincinnati Bengals. Hendrickson, 29, has recorded 27 sacks over the past three seasons and provides a more immediate, lower-risk option for Baltimore’s defense.
Hendrickson’s arrival doesn’t erase the sting of missing out on Crosby, a player many considered a potential game-changer. However, it demonstrates the Ravens’ ability to adapt and find alternative solutions. The team clearly prioritized adding an impact player at the edge position and successfully did so, even after a high-profile trade fell through.
The Long-Term Implications
The situation highlights the inherent risks involved in blockbuster trades, particularly when significant draft capital is at stake. Teams must balance the potential reward of acquiring a star player with the possibility of unforeseen medical issues. The Ravens, known for their meticulous approach to player evaluation, ultimately decided the risk associated with Crosby’s knee outweighed the potential benefits.
For the Raiders, retaining Crosby is a win, but the failed trade raises questions about their long-term plans and their ability to build a consistent contender. The team will need to carefully manage Crosby’s health and workload to ensure he remains a productive force for years to come. The incident also underscores the importance of transparency and clear communication between teams during trade negotiations.
The NFL offseason is often characterized by speculation and dramatic twists. The Crosby saga serves as a reminder that even seemingly done deals can unravel, and that medical evaluations play a crucial role in shaping the future of the league. The next key date for both teams will be the start of the NFL Draft in April, where the Ravens will now utilize the draft capital they retained, and the Raiders will continue to build around their core players.
What do you think of the Ravens’ decision? Share your thoughts in the comments below, and be sure to share this article with fellow NFL fans.
